+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Helicobacter Pylori Testing Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6282304
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Helicobacter Pylori Testing: Executive Overview

Helicobacter pylori testing supports the diagnosis of active infection and the confirmation of eradication after treatment. Common approaches include urea breath testing, stool antigen testing, endoscopic biopsy-based methods, and serology. Clinical adoption is shaped by diagnostic accuracy, patient access, laboratory capacity, treatment pathways, and adherence to testing guidance. The field is moving toward noninvasive, evidence-based workflows that connect diagnosis with appropriate therapy and post-treatment verification.

Testing Pathways Are Shifting Toward Noninvasive Confirmation

Healthcare systems are increasingly emphasizing noninvasive tests for initial assessment and test-of-cure, particularly where endoscopy is not clinically indicated. Urea breath and stool antigen methods are generally favored for detecting active infection, while serology has a more limited role because antibodies may persist after eradication. Pre-analytic requirements, including appropriate medication washout, remain important because acid-suppressing drugs and recent antimicrobial exposure can affect results. Integration with antimicrobial stewardship is also becoming more important as clinicians seek to avoid unnecessary treatment and confirm successful eradication.

Artificial Intelligence Is Strengthening Diagnostic Workflow Rather Than Replacing Testing

Artificial intelligence can support Helicobacter pylori testing through pathology image analysis, decision support, laboratory quality control, and identification of patients who may benefit from evaluation. Its practical value depends on representative training data, transparent validation, interoperability with laboratory and clinical systems, and appropriate clinician oversight. AI-assisted endoscopic image interpretation may help identify suspicious mucosal findings, but microbiological or histological confirmation remains necessary. Privacy safeguards, bias monitoring, and regulatory compliance are essential before deploying AI in routine care.

Regional Differences Reflect Access, Guidelines, and Diagnostic Infrastructure

North America generally emphasizes guideline-based noninvasive testing, medication management before testing, and confirmation of eradication. Latin America faces a substantial need for accessible diagnostics, with implementation influenced by uneven laboratory capacity and local antimicrobial-resistance patterns. Europe benefits from established clinical guidance and broad laboratory networks, although access and screening practices differ across countries. The Middle East shows varied adoption linked to healthcare investment, referral pathways, and specialist availability. Africa continues to face constraints involving affordability, geographic access, laboratory infrastructure, and follow-up. Asia-Pacific combines advanced diagnostic systems in some economies with large populations, diverse healthcare settings, and continuing needs for scalable, affordable testing.

International Groups Are Aligning Testing With Stewardship and Health-System Priorities

ASEAN members require adaptable approaches that account for diverse health systems, urban-rural access gaps, and laboratory capacity. BRICS countries span highly different diagnostic infrastructures, making decentralized testing, quality assurance, and affordable supply important considerations. The European Union benefits from shared scientific frameworks while retaining national differences in reimbursement and implementation. G7 health systems generally have stronger laboratory networks but still face challenges involving appropriate referral, medication interference, and follow-up adherence. GCC countries can leverage concentrated healthcare infrastructure while addressing workforce and access variation. NATO members may benefit from interoperable clinical standards and resilient supply chains, although testing policies remain nationally determined.

Country Conditions Shape Adoption, Access, and Clinical Use

Australia and Canada generally support structured, guideline-informed testing through established healthcare networks. Brazil, Mexico, Russia, India, and China present substantial variation between major urban centers and less-resourced settings, making affordability, decentralized services, and laboratory quality especially relevant. France, Germany, Italy, Spain, and the United Kingdom have mature clinical and laboratory systems, with implementation influenced by national guidance, reimbursement, and referral practices. Japan and South Korea have advanced diagnostic capabilities, while continued attention to appropriate indications and eradication confirmation remains important. Across the United States, testing pathways are shaped by primary-care access, insurer policies, clinical guidelines, and the need to manage medication-related false-negative risk.

Industry Leaders Should Build Reliable, Clinically Integrated Testing Pathways

Leaders should prioritize validated noninvasive workflows, clear medication-washout instructions, and dependable test-of-cure protocols. Partnerships with clinicians and laboratories can improve appropriate patient selection, result interpretation, and follow-up completion. Products and services should be designed for different infrastructure levels, including decentralized settings where transport and laboratory access are limited. Organizations should also invest in quality assurance, antimicrobial-resistance surveillance, interoperable reporting, and responsible AI validation. Education for clinicians and patients can reduce inappropriate testing, improve adherence, and reinforce the distinction between detecting active infection and detecting prior exposure.

Methodology: Evidence-Based Synthesis of Clinical and Health-System Factors

This executive summary uses the supplied market scope and required geographic groupings as the organizing framework. The analysis synthesizes established clinical principles concerning Helicobacter pylori detection, noninvasive and endoscopic testing modalities, medication interference, eradication confirmation, laboratory quality, antimicrobial stewardship, and responsible use of artificial intelligence. Regional, group, and country observations are presented qualitatively and are not intended to provide market estimates, forecasts, shares, or rankings. Interpretations should be validated against current local guidelines, regulatory requirements, reimbursement policies, and epidemiological evidence before operational use.

Effective Testing Depends on Accuracy, Access, and Follow-Through

The Helicobacter pylori testing landscape is defined by a shift toward accurate noninvasive diagnosis, reliable confirmation of eradication, and closer integration with treatment stewardship. Technology, including AI, can improve workflow and interpretation when supported by high-quality data and clinical oversight. However, regional and country-level differences in infrastructure, affordability, guidance, and follow-up remain decisive. Industry leaders that combine validated diagnostics with clear clinical pathways, quality systems, responsible innovation, and patient education will be best positioned to support consistent care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Helicobacter Pylori Testing Market, by Test Type
7.1. Introduction
7.2. Non Invasive Tests
7.2.1. Urea Breath Test
7.2.2. Stool Antigen Test
7.2.3. Serology Test
7.3. Invasive Tests
7.3.1. Culture Test
7.3.2. Molecular Diagnostic Test
8. Helicobacter Pylori Testing Market, by Technology
8.1. Introduction
8.2. Immunoassay
8.2.1. ELISA
8.2.2. Lateral Flow Assay
8.3. Molecular Diagnostics
8.4. Breath Analysis Technology
8.5. Microscopy Based Techniques
9. Helicobacter Pylori Testing Market, by Mode of Testing
9.1. Introduction
9.2. Manual Testing
9.3. Semi Automated Testing
9.4. Fully Automated Testing
10. Helicobacter Pylori Testing Market, by End User
10.1. Introduction
10.2. Hospitals
10.3. Diagnostic Laboratories
10.4. Clinics
10.5. Academic & Research Institutes
11. Helicobacter Pylori Testing Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Helicobacter Pylori Testing Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Helicobacter Pylori Testing Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Agilent Technologies Inc
15.3. Alfa Scientific Designs Inc
15.4. Avanos Medical Inc
15.5. Bio-Rad Laboratories Inc
15.6. Biohit Oyj
15.7. bioMerieux SA
15.8. Cardinal Health Inc
15.9. CerTest Biotec S.L.
15.10. Coris BioConcept SPRL
15.11. CTK Biotech Inc
15.12. DiaSorin S.p.A.
15.13. Epitope Diagnostics Inc
15.14. F. Hoffmann-La Roche Ltd
15.15. Laboratory Corporation of America Holdings
15.16. Medline Industries LP
15.17. Meridian Bioscience Inc
15.18. QIAGEN N.V.
15.19. Quest Diagnostics Incorporated
15.20. QuidelOrtho Corporation
15.21. Sekisui Diagnostics LLC
15.22. Shenzhen Zhonghe Headway Bio-Sci & Tech Co Ltd
15.23. Siemens Healthineers AG
15.24. TECHLAB Inc
15.25. Thermo Fisher Scientific Inc
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Helicobacter Pylori Testing Market, Years Considered for the Study
FIGURE 2. Global Helicobacter Pylori Testing Market, Research Design
FIGURE 3. Global Helicobacter Pylori Testing Market, Research Framework
FIGURE 4. Global Helicobacter Pylori Testing Market, Data Triangulation
FIGURE 5. Global Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Helicobacter Pylori Testing Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 7. Global Helicobacter Pylori Testing Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Helicobacter Pylori Testing Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Helicobacter Pylori Testing Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Helicobacter Pylori Testing Market Size, by Mode of Testing, 2025 vs 2032 (%)
FIGURE 11. Global Helicobacter Pylori Testing Market Size, by Mode of Testing, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Helicobacter Pylori Testing Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Helicobacter Pylori Testing Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Helicobacter Pylori Testing Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Helicobacter Pylori Testing Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Helicobacter Pylori Testing Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Helicobacter Pylori Testing Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Helicobacter Pylori Testing Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Helicobacter Pylori Testing Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Helicobacter Pylori Testing Market Segmentation & Coverage
TABLE 2. Global Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 3. Global Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 4. Global Non Invasive Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Non Invasive Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Non Invasive Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Urea Breath Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Urea Breath Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Urea Breath Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Stool Antigen Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Stool Antigen Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Stool Antigen Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Serology Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Serology Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Serology Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Invasive Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Invasive Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Invasive Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Culture Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Culture Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Culture Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Molecular Diagnostic Test Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Molecular Diagnostic Test Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Molecular Diagnostic Test Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 26. Global Immunoassay Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Immunoassay Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Immunoassay Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global ELISA Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global ELISA Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global ELISA Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Lateral Flow Assay Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Lateral Flow Assay Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Lateral Flow Assay Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Breath Analysis Technology Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Breath Analysis Technology Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Breath Analysis Technology Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Microscopy Based Techniques Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Microscopy Based Techniques Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Microscopy Based Techniques Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 45. Global Manual Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Manual Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Manual Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Semi Automated Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Semi Automated Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Semi Automated Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Fully Automated Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Fully Automated Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Fully Automated Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 55. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Helicobacter Pylori Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Helicobacter Pylori Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 70. Asia-Pacific Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 71. Asia-Pacific Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. North America Helicobacter Pylori Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. North America Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 78. North America Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 79. North America Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 80. North America Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 81. North America Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 82. North America Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 83. North America Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Latin America Helicobacter Pylori Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Latin America Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 86. Latin America Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 87. Latin America Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 88. Latin America Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 89. Latin America Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 90. Latin America Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 91. Latin America Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Europe Helicobacter Pylori Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Europe Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 94. Europe Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 95. Europe Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 96. Europe Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 97. Europe Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 98. Europe Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 99. Europe Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Middle East Helicobacter Pylori Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Middle East Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 102. Middle East Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 103. Middle East Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 104. Middle East Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 105. Middle East Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 106. Middle East Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 107. Middle East Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Africa Helicobacter Pylori Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Africa Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 110. Africa Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 111. Africa Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 112. Africa Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 113. Africa Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 114. Africa Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 115. Africa Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Global Helicobacter Pylori Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. ASEAN Helicobacter Pylori Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. ASEAN Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 119. ASEAN Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 120. ASEAN Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 121. ASEAN Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 122. ASEAN Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 123. ASEAN Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 124. ASEAN Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. GCC Helicobacter Pylori Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. GCC Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 127. GCC Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 128. GCC Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 129. GCC Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 130. GCC Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 131. GCC Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 132. GCC Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. European Union Helicobacter Pylori Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. European Union Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 135. European Union Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 136. European Union Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 137. European Union Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 138. European Union Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 139. European Union Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 140. European Union Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. BRICS Helicobacter Pylori Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. BRICS Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 143. BRICS Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 144. BRICS Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 145. BRICS Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 146. BRICS Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 147. BRICS Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 148. BRICS Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. G7 Helicobacter Pylori Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. G7 Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 151. G7 Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 152. G7 Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 153. G7 Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. G7 Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 155. G7 Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 156. G7 Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. NATO Helicobacter Pylori Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 158. NATO Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 159. NATO Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 160. NATO Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 161. NATO Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 162. NATO Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 163. NATO Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 164. NATO Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Global Helicobacter Pylori Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. United States Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 167. United States Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 168. United States Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 169. United States Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 170. United States Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 171. United States Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 172. United States Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 173. United States Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Canada Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 175. Canada Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 176. Canada Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 177. Canada Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 178. Canada Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 179. Canada Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 180. Canada Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 181. Canada Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Mexico Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 183. Mexico Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 184. Mexico Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 185. Mexico Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 186. Mexico Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 187. Mexico Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 188. Mexico Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 189. Mexico Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Brazil Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 191. Brazil Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 192. Brazil Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 193. Brazil Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 194. Brazil Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 195. Brazil Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 196. Brazil Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 197. Brazil Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. United Kingdom Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 199. United Kingdom Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 200. United Kingdom Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 201. United Kingdom Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 202. United Kingdom Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 203. United Kingdom Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 204. United Kingdom Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 205. United Kingdom Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Germany Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 207. Germany Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 208. Germany Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 209. Germany Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 210. Germany Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 211. Germany Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 212. Germany Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 213. Germany Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. France Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 215. France Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 216. France Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 217. France Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 218. France Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 219. France Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 220. France Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 221. France Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Russia Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 223. Russia Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 224. Russia Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 225. Russia Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 226. Russia Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 227. Russia Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 228. Russia Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 229. Russia Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Italy Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 231. Italy Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 232. Italy Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 233. Italy Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 234. Italy Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 235. Italy Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 236. Italy Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 237. Italy Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Spain Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 239. Spain Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 240. Spain Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 241. Spain Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 242. Spain Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 243. Spain Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 244. Spain Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 245. Spain Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. China Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 247. China Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 248. China Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 249. China Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 250. China Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 251. China Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 252. China Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 253. China Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. India Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 255. India Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 256. India Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 257. India Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 258. India Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 259. India Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 260. India Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 261. India Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Japan Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 263. Japan Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 264. Japan Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 265. Japan Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 266. Japan Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 267. Japan Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 268. Japan Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 269. Japan Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Australia Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 271. Australia Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 272. Australia Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 273. Australia Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 274. Australia Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 275. Australia Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 276. Australia Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 277. Australia Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. South Korea Helicobacter Pylori Testing Market Size, 2017-2032 (USD Million)
TABLE 279. South Korea Helicobacter Pylori Testing Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 280. South Korea Helicobacter Pylori Testing Market Size, by Non Invasive Tests, 2017-2032 (USD Million)
TABLE 281. South Korea Helicobacter Pylori Testing Market Size, by Invasive Tests, 2017-2032 (USD Million)
TABLE 282. South Korea Helicobacter Pylori Testing Market Size, by Technology, 2017-2032 (USD Million)
TABLE 283. South Korea Helicobacter Pylori Testing Market Size, by Immunoassay, 2017-2032 (USD Million)
TABLE 284. South Korea Helicobacter Pylori Testing Market Size, by Mode of Testing, 2017-2032 (USD Million)
TABLE 285. South Korea Helicobacter Pylori Testing Market Size, by End User, 2017-2032 (USD Million)
TABLE 286. Global Helicobacter Pylori Testing Market Share, by Key Player, 2025
TABLE 287. Global Helicobacter Pylori Testing Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Alfa Scientific Designs Inc
  • Avanos Medical Inc
  • Bio-Rad Laboratories Inc
  • Biohit Oyj
  • bioMerieux SA
  • Cardinal Health Inc
  • CerTest Biotec S.L.
  • Coris BioConcept SPRL
  • CTK Biotech Inc
  • DiaSorin S.p.A.
  • Epitope Diagnostics Inc
  • F. Hoffmann-La Roche Ltd
  • Laboratory Corporation of America Holdings
  • Medline Industries LP
  • Meridian Bioscience Inc
  • QIAGEN N.V.
  • Quest Diagnostics Incorporated
  • QuidelOrtho Corporation
  • Sekisui Diagnostics LLC
  • Shenzhen Zhonghe Headway Bio-Sci & Tech Co Ltd
  • Siemens Healthineers AG
  • TECHLAB Inc
  • Thermo Fisher Scientific Inc